Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

456
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
456
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

832
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
832

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Burden and distribution of multidrug-resistant bacteria among hospitalized patients with cirrhosis: A systematic review and meta-analysis.

Clinics and research in hepatology and gastroenterology·2026
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026
Same author

Effectiveness of sodium-glucose cotransporter 2 inhibitors in patients with metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis of randomized controlled trials.

European journal of gastroenterology & hepatology·2026
Same author

MRI multicomponent relaxometry for liver fibrosis, inflammation, and steatosis in nonalcoholic steatohepatitis: A prospective study.

European journal of radiology·2026
Same author

Blood multiomics reveal a dysregulated lipid mediator-mitochondrial network associated with the outcome of advanced cirrhosis.

Nature communications·2026
Same author

Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta-Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026

相关实验视频

Updated: Mar 14, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K

密码性慢性肝炎:寻找一个理想的诊断算法.

Guilherme Grossi Lopes Cançado1, Aline Coelho Rocha Candolo2, Mateus Jorge Nardelli1

  • 1Instituto Alfa de Gastroenterologia, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Frontiers in gastroenterology (Lausanne, Switzerland)
|March 13, 2026
PubMed
概括
此摘要是机器生成的。

现在可以使用新的算法更好地诊断密码性慢性肝炎,该算法将代谢功能障碍相关的脂肪肝疾病 (MAFLD) 和 lysosomal acid lipase 缺乏症 (LAL-D) 确定为关键原因,从而改善患者管理.

关键词:
算法算法是一种算法.密码性的肝硬化症密码性肝炎是一种隐藏性肝炎.诊断 诊断 诊断 诊断 诊断 诊断与代谢相关的脂肪肝疾病.非酒精性脂肪性肝病是非酒精性脂肪性肝病.

更多相关视频

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.9K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.0K

相关实验视频

Last Updated: Mar 14, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.9K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.0K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 内部医学 内部医学
  • 胃肠病学 胃肠病学

背景情况:

  • 密码性慢性肝炎是肝移植的原因越来越多,占慢性肝病病例的5%-15%.
  • 确定肝病的潜在病因对于有效的患者管理和治疗策略至关重要.

研究的目的:

  • 为了确定巴西队列中的密码性肝病的原因.
  • 开发和验证密码性肝炎的新诊断算法,包括代谢功能障碍相关的脂肪肝疾病 (MAFLD) 和 lysosomal acid lipase deficiency (LAL-D).

主要方法:

  • 对326名疑似患有密码性肝炎的患者进行了回顾性分析.
  • 应用Czaja的算法进行初始的病因诊断.
  • 开发一个更新的算法,包括MAFLD和LAL-D调查.
  • 在肝移植受体中对扩展体组织学进行后期分析.

主要成果:

  • 传统的算法在21.3%的患者中诊断出非酒精性脂肪性肝病,在1%的患者中诊断出LAL-D,剩下的53.6%未被诊断出来.
  • 将MAFLD纳入新算法将诊断率提高到49.1%,未被诊断的病例减少了11.4%.
  • 移植后的探索性分析显示,52.5%的患者患有非酒精性脂肪肝炎.

结论:

  • 大约三分之一的疑似密码性肝病患者被诊断患有MAFLD.
  • 在对源不明的慢性肝病的病因学调查中,应考虑溶酶体酸脂酶缺乏症 (LAL-D).
  • 拟议的更新诊断算法提高了密码性肝炎的诊断准确性,有助于临床管理.